Exploring preferences for different modes of cannabis use during early pregnancy: A qualitative study.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
11 2023
Historique:
received: 14 06 2023
revised: 12 07 2023
accepted: 19 07 2023
medline: 7 8 2023
pubmed: 26 7 2023
entrez: 25 7 2023
Statut: ppublish

Résumé

Rates of prenatal cannabis use are rising, yet little is known about modes of cannabis use during pregnancy. This focus group study with pregnant individuals aimed to examine use patterns and perceptions regarding common modes of prenatal cannabis use. Kaiser Permanente Northern California pregnant adult patients who identified as White or Black and self-reported cannabis use during pregnancy were recruited to participate (N = 53; 40% Black, 60% White; Mean A range of modes were preferred, with no single mode predominant. Participants' preferences aligned with four themes: perceived effects and benefits of cannabis, health and safety, convenience and familiarity, and partner and friend influences. Participants sought modes that were accessible and familiar, provided consistent and quick relief for pregnancy-related symptoms, were aligned with partners or friends, and minimized perceived risks while also providing symptom relief. Participants desired evidence-based information about mode safety to better inform mode selection during pregnancy. A range of personal and social factors influenced mode preferences during pregnancy. Many participants desired to reduce harms and use cannabis more safely in pregnancy but received little mode-specific information to guide these preferences. Further research identifying mode-specific risks is needed to guide harm reduction approaches during pregnancy.

Identifiants

pubmed: 37490827
pii: S0306-4603(23)00207-1
doi: 10.1016/j.addbeh.2023.107812
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107812

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA043604
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007250
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Maha N Mian (MN)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, CA, United States. Electronic address: Maha.mian@ucsf.edu.

Tara R Foti (TR)

College of Public Health, University of South Florida, United States.

Andrea Green (A)

Early Start Program, Kaiser Permanente Northern California, Sacramento, CA, United States.

Esti Iturralde (E)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.

Andrea Altschuler (A)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.

Monique B Does (MB)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.

Melanie Jackson-Morris (M)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.

Sara R Adams (SR)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.

Derek D Satre (DD)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, CA, United States.

Deborah Ansley (D)

Regional Offices, Kaiser Permanente Northern California, Oakland, CA, United States.

Kelly C Young-Wolff (KC)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH